NASDAQ · MDXH
MDxHealth SA financials
$0.5200−5.11%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 |
|---|---|---|---|---|---|
| Revenue | $107.9M | $90.0M | $70.2M | $0.00 | $22.2M |
| Gross profit | $69.6M | $55.1M | $43.9M | $0.00 | $10.6M |
| Gross margin | 64.5% | 61.2% | 62.6% | — | 47.5% |
| Operating income | -$14.4M | -$24.7M | -$27.3M | $0.00 | -$26.8M |
| Net income | -$33.5M | -$38.1M | -$43.1M | $0.00 | -$29.0M |
| Net margin | −31.1% | −42.3% | −61.4% | — | −130.4% |
| Diluted EPS | $-0.67 | $-1.16 | $-1.66 | $0.00 | $-2.38 |
| EBITDA | -$5.2M | -$16.7M | -$20.5M | $4.9M | -$23.8M |
| Operating cash flow | -$2.2M | -$18.5M | -$21.5M | -$34.1M | -$22.5M |
| Free cash flow | -$23.0M | -$20.3M | -$24.2M | -$36.9M | -$23.4M |
| Diluted shares | 50.0M | 32.9M | 25.9M | — | 12.2M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|
| Cash & equivalents | $29.0M | $46.8M | $22.4M | $15.5M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $106.8M | $77.7M | $36.2M | $35.5M |
| Total assets | $148.0M | $157.3M | $129.1M | $119.1M |
| Total liabilities | $160.0M | $142.5M | $121.9M | $109.8M |
| Shareholders' equity | -$12.1M | $14.8M | $7.2M | $9.3M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology